Study assesses effectiveness of strategies to prevent SARS-CoV-2 transmission in healthcare settings

In a recent study published in Clinical Infectious Diseases, researchers used large-scale viral genomic and social network analyses to determine whether infection prevention (IP) measures used during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic were adequate in protecting healthcare workers (HCWs) and patients from acquiring SARS-CoV-2.

Health care worker with PPE
Study: Integrated Genomic and Social Network Analyses of Severe Acute Respiratory Syndrome Coronavirus 2 Transmission in the Healthcare Setting. Image Credit: Cryptographer/Shutterstock.com

Infection prevention protocols in healthcare have been used to prevent infectious diseases for decades, but limited clinical information supports their effectiveness. During the coronavirus disease 2019 (COVID-19) pandemic, SARS-CoV-2 transmission was widespread and personal protective equipment (PPE) availability was limited.

Researchers performed genetic analysis to eliminate spurious associations between cases and transmission. Despite these steps, COVID-19 incidence has decreased among HCWs. The lack of specialized research to assess the efficiency of infection control methods, such as PPE and optimal air exchange and filtration, has led to disparate approaches and ongoing uncertainties regarding their efficacy.

About the study

In the present cross-sectional, retrospective study, researchers investigated whether the electronic contact record (ECR) algorithm and IP protocols during three COVID-19 waves (including the period of Omicron BA.1 and B.1.1.526 variants’ emergence towards the end of 2021) identified and effectively mitigated SARS-CoV-2 transmission in healthcare settings.

The study, conducted from November 2020 to January 2022, involved individuals testing SARS-CoV-2-positive using polymerase chain reaction (PCR) at the University of California San Diego Health (UCSDH).

The team analyzed viral genomics from the samples and performed a social network assessment using electronic health records (EHRs) to derive temporospatial overlap of infections among related viromes and establish contacts among SARS-CoV-2-infected healthcare workers and patients.

The study outcome measure was any instance of SARS-CoV-2 transmission in HCWs, defined as cases within the healthcare setting, during the infection window, with closely related viral genomes and epidemiological connections. The team subjected SARS-CoV-2-positive specimens to whole-genome sequencing (WGS) to identify potential health system transmissions of SARS-CoV-2.

Researchers conducted weekly testing on symptomatic and unvaccinated healthcare workers, with vaccinated individuals being tested weekly during high community prevalence periods. They compared social network analysis findings to those of maximum likelihood phylogenetic and genomic evaluations of the viral sequences to assess epidemiological associations.

The HCWs filled out COVID-19 symptom surveys daily, and positive symptoms or known exposures prompted referrals for testing. To validate the ECR algorithm, the team examined its effectiveness in successfully ruling out unrelated cases through case tracing.

Results

The team obtained high-grade whole-genomic sequences of SARS-CoV-2 from 12,933 individuals and detected 2,397 interaction pairs in the electronic contact record. The Omicron-infected population was older and had a higher likelihood of being vaccinated at the time of the SARS-CoV-2-positive tests, with a higher percentage of healthcare workers than individuals contracting SARS-CoV-2 in the prior two waves.

The ECR algorithm determined 291 contact pairs among 7,821 sequences, with 34 pairs having genomically associated viral sequences. The remnant 257 pairs were inconsistent with SARS-CoV-2 transmission, suggesting they were more genomically associated with SARS-CoV-2.

The 34 genetically related contacts comprised 13 clusters: three indicated healthcare transmission. To find gaps, the scientists broadened the cluster groupings to incorporate individuals with genetically similar viral genomes.

During December 2021 and January 2022, 1,376 HCWs contracted SARS-CoV-2, an increase of more than 800% from the previous two months. Most transmission events in healthcare pairs were observed at the hospital’s Hillcrest campus: 11 pairs (79%) in the second-third COVID-19 waves and 18 pairs (75%) during the Omicron wave, contrary to three pairs and five pairs identified at the newer La Jolla campus, respectively.

In total, 39 individuals and 13 individuals (patients and HCWs) were involved in the likely transmission of SARS-CoV-2 at the Hillcrest and La Jolla campuses, respectively. SARS-CoV-2 transmission rates per 1,000 admissions were 2.5 and 0.6 at the Hillcrest and La Jolla campuses, respectively.

In addition, most individuals who transmitted or acquired the COVID-19-causing virus in the nosocomial settings were placed in shared rooms during their stay (six out of six individuals in the second-third COVID-19 waves, four of six patients during the Omicron wave).

The team identified no transmission events from exposures through COVID-19 patient rooms left open or patients placed in non-negative pressure-type rooms, except SARS-CoV-2 exposure to those sharing rooms and their healthcare providers. The team also identified no SARS-CoV-2 transmission to healthcare workers from individuals admitted to intensive care units due to COVID-19.

Conclusions

Overall, the study findings showed that IP strategies effectively prevent SARS-CoV-2 transmission in healthcare settings, with most events occurring between HCWs or in shared patient rooms in older hospitals.

There were no healthcare-associated transmissions among individuals identified with the infection. The findings support multipronged, scalable infection control protocols to control SARS-CoV-2 transmission.

Journal reference:
Pooja Toshniwal Paharia

Written by

Pooja Toshniwal Paharia

Pooja Toshniwal Paharia is an oral and maxillofacial physician and radiologist based in Pune, India. Her academic background is in Oral Medicine and Radiology. She has extensive experience in research and evidence-based clinical-radiological diagnosis and management of oral lesions and conditions and associated maxillofacial disorders.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Toshniwal Paharia, Pooja Toshniwal Paharia. (2024, January 22). Study assesses effectiveness of strategies to prevent SARS-CoV-2 transmission in healthcare settings. News-Medical. Retrieved on December 28, 2024 from https://www.news-medical.net/news/20240122/Study-assesses-effectiveness-of-strategies-to-prevent-SARS-CoV-2-transmission-in-healthcare-settings.aspx.

  • MLA

    Toshniwal Paharia, Pooja Toshniwal Paharia. "Study assesses effectiveness of strategies to prevent SARS-CoV-2 transmission in healthcare settings". News-Medical. 28 December 2024. <https://www.news-medical.net/news/20240122/Study-assesses-effectiveness-of-strategies-to-prevent-SARS-CoV-2-transmission-in-healthcare-settings.aspx>.

  • Chicago

    Toshniwal Paharia, Pooja Toshniwal Paharia. "Study assesses effectiveness of strategies to prevent SARS-CoV-2 transmission in healthcare settings". News-Medical. https://www.news-medical.net/news/20240122/Study-assesses-effectiveness-of-strategies-to-prevent-SARS-CoV-2-transmission-in-healthcare-settings.aspx. (accessed December 28, 2024).

  • Harvard

    Toshniwal Paharia, Pooja Toshniwal Paharia. 2024. Study assesses effectiveness of strategies to prevent SARS-CoV-2 transmission in healthcare settings. News-Medical, viewed 28 December 2024, https://www.news-medical.net/news/20240122/Study-assesses-effectiveness-of-strategies-to-prevent-SARS-CoV-2-transmission-in-healthcare-settings.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
FDA strengthens AI regulation to ensure patient safety and innovation in healthcare